Skip to Content

LAMISIL AT 1% CREAM

Active substance(s): TERBINAFINE HYDROCHLORIDE / TERBINAFINE HYDROCHLORIDE / TERBINAFINE HYDROCHLORIDE

View full screen / Print PDF » Download PDF ⇩

PDF Transcript

9 mm

Recto

145 mm

Read all of this leaflet carefully because it contains
important information for you.
This medicine is available without prescription. However,
• Dhobie itch/jock itch (tinea cruris) – Dhobie itch
you still need to use Lamisil AT 1% Cream carefully to get
appears in the groin and inner thigh area, usually on
the best results from it.
both sides but often with one side more than the other,
–– Please keep this leaflet. You may need to read it again.
where it can spread further between the legs to the
–– Ask your pharmacist if you need more information or
buttocks, or up towards the stomach. Dhobie itch
advice.
looks like a clearly bordered rash, which may have
–– You must contact a doctor if your symptoms worsen or
blisters.
do not improve.
–– If any of the side effects get serious, or if you notice
2. Before you use Lamisil AT 1% Cream
any side effect not listed in this leaflet, please tell your
doctor or pharmacist.
DO NOT use Lamisil AT 1% Cream if you:
• are allergic (hypersensitive) to any of the ingredients
In this leaflet:
in the product (see Section 6).
1. What Lamisil AT 1% Cream is and what it is used for
The cream is NOT recommended for use on children
2. Before you use Lamisil AT 1% Cream
under 16 years of age.
3. How to use Lamisil AT 1% Cream
4. Possible side effects
5. How to store Lamisil AT 1% Cream
6. Further information.

1. What Lamisil AT 1% Cream is and what
it is used for

Taking other medicines
Please tell your doctor or pharmacist if you are taking or
have recently taken any other medicines, including those
obtained without a prescription.
Pregnancy and breast-feeding
Do not use the cream if you are pregnant or breastfeeding, unless advised to by your doctor.

Driving and using machines
Lamisil AT 1% Cream is not expected to affect your ability
to drive or operate machinery.
Important information about some of the ingredients
of Lamisil AT 1% Cream
• cetyl alcohol and stearyl alcohol: May cause local skin
reactions (e.g. contact dermatitis).

3. How to use Lamisil AT 1% cream
Always use this medicine exactly as described in this
leaflet or as advised by your doctor or pharmacist.
Adults
For Athlete’s Foot and dhobie itch, apply the cream once
a day, for one week.
• Cleanse and dry the affected areas thoroughly and
wash your hands. Treatment can be helped by keeping
the affected areas clean by regular washing and
careful drying with your own clean towels and clothes,
and not rubbing or scratching the skin.
• Unscrew the cap then gently squeeze out a small
amount of the cream onto your finger.
• Apply just enough cream to form a thin layer on the
affected skin and surrounding areas.
• Rub in gently. When used between the toes, buttocks
or on the groin, the treated area may be covered with
a light, fresh gauze strip, especially at night.
• Replace the cap on the tube and wash your hands.
Even though you will not be using Lamisil AT 1% Cream
during the second week, full skin healing after the infection has cleared will continue for up to 4 weeks. If you
have not noticed any signs of improvement within
2 weeks of first starting treatment, please seek advice
from your doctor or pharmacist.

9 mm

Lamisil AT 1% Cream contains the active ingredient
terbinafine hydrochloride which is an antifungal used to
treat fungal skin infection such as:
• Athlete’s foot (tinea pedis) – Athlete’s foot appears
only on the feet (usually both, but not always), usually
in between the toes. It can also appear on the instep,

Take special care with Lamisil AT 1% cream
The cream is for external use only. Do not use on the
face. Avoid contact with the eyes. In case of accidental
contact with eyes, rinse thoroughly with running water.

Ask your doctor or pharmacist for advice before taking
any medicine.

127 mm

soles, or other areas of the feet. The most common
type of athlete’s foot causes cracking or scaling of
the skin, but you may also have mild swelling, blisters,
or weeping ulcers. Lamisil AT 1% Cream is recommended for athlete’s foot when it occurs between the
toes. If you have a fungal nail infection (fungus inside
and under the nail) with discolouration of the nails and
changes in nail texture (thick or flaky), you should
consult your doctor because Lamisil AT 1% Cream is
not appropriate for this type of infection.

Pharma code XXX
210 mm

72 mm

11,5 mm

11,5 mm

9 mm

Verso

If you accidently swallow Lamisil AT 1% Cream
Contact your doctor or nearest hospital emergency
department if you, or someone else, has swallowed some
cream. Take any remaining medicine and this leaflet with
you if possible. Symptoms of accidental ingestion include
headache, nausea (feeling sick), dizziness and stomach
pain.

145 mm

If you forget to use Lamisil AT 1% Cream
If you miss an application, apply the cream as soon as
possible then continue your treatment as before. If you
only remember at the time of your next application, just
apply the cream and carry on as normal. It is important
to try to use the cream at the correct times as forgotten
applications could risk the infection returning.
If you stop using Lamisil AT 1% Cream
Infections may come back if you do not use the cream
regularly, or if you stop the treatment too early. If you
have any further questions on the use of this product, ask
your doctor or pharmacist.

4. Possible side effects
Like all medicines, Lamisil AT 1% Cream can cause side
effects, although not everybody gets them.
STOP using the cream and seek medical help
immediately if you have any of the following very rare
allergic reactions:
• difficulty breathing or swallowing, swelling of the
mouth, face, lips, tongue or throat (severe allergic
reaction)
• severe itching of the skin, with a red rash or raised
lumps, hives or blisters.

These common and uncommon side effects are usually
harmless and you can carry on using the cream.

What Lamisil AT 1% Cream looks like and contents of
the pack
The cream is available in aluminium or laminate tubes
of 7 g, 7.5 g, 10 g or 15 g.
Not all pack sizes may be marketed.

Rare: (may affect up to 1 in 1000 people): eye irritation,
dry skin, contact dermatitis, eczema, worsening of symptoms.

Marketing Authorisation Holder and Manufacturer
GlaxoSmithKline Consumer Healthcare (UK) Trading
Limited, Brentford, TW8 9GS, U.K.

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist
or nurse. This includes any possible side effects not listed
in this leaflet. You can also report side effects directly via
the Yellow Card Scheme at:
www.mhra.gov.uk/yellowcard
By reporting side effects you can help provide more
information on the safety of this medicine.

® Lamisil is a registered trademark owned by or
licensed to the GSK group of companies.
This leaflet was last revised in February 2016

5. How to store Lamisil AT 1% Cream
Keep out of the sight and reach of children.
Keep the tube closed and in the carton.
Do not use this medicine after the expiry (EXP) date
shown on the box and tube.
Medicines should not be disposed of via wastewater or
household waste. Ask your pharmacist how to dispose of
medicines no longer required. These measures will help
to protect the environment.

6. Further information
What Lamisil AT 1% Cream contains
The active ingredient is terbinafine hydrochloride
1% w/w.
The other ingredients are sodium hydroxide, benzyl
alcohol, sorbitan stearate, cetyl palmitate, cetyl alcohol,
stearyl alcohol, polysorbate 60, isopropyl myristate,
purified water. (See also end of Section 2 for further
information on some of the ingredients).

GB XXXXXX - GB 316737
9 mm

Common: (may affect up to 1 in 10 people): skin peeling,
itching.

Uncommon: (may affect up to 1 in 100 people): skin
lesions, scab, skin colour changes, redness, burning, pain
and irritation at the site of application.

127 mm

Children under 16 years
NOT recommended.

Pharma code XXX
210 mm

72 mm

11,5 mm

11,5 mm

Expand Transcript

Source: Medicines and Healthcare Products Regulatory Agency

Disclaimer: Every effort has been made to ensure that the information provided here is accurate, up-to-date and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. This information has been compiled for use by healthcare practitioners and consumers in the United States. The absence of a warning for a given drug or combination thereof in no way should be construed to indicate that the drug or combination is safe, effective or appropriate for any given patient. If you have questions about the substances you are taking, check with your doctor, nurse or pharmacist.

Hide